CClinicalTrials.gg
RecruitingNCT06592248ForgottenKneUpdated Jan 15, 2025

Evaluation of a New Bi-Condylar Total Knee Prosthesis (TKP) With All-Ceramic Friction (The Forgotten Knee)

An interventional study of Coc Knee in Knee Osteoarthritis, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-01-15.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The results of TKP (Total Knee Prosthesis) are satisfactory but do not reach those of THP (Total Hip Prosthesis) in terms of indolence and function. By using an all-ceramic friction torque, identical to that of the hip, the promotor of this Clinical Investigation expects to obtain an improvement in term of indolence, ability to perform heavy activities, knee stability and an improvement in the long-term survival of TKP, while at the same time, a decrease in the rate of re-intervention in young patients.

Read the detailed description

The aim of this study is to evaluate the all-ceramic knee prosthesis, according to clinical and radiological criteria of usual follow-up of a TKP for knee osteoarthritis, at 12 months.

Evaluation of clinical and radiographic endpoints at 12 months:

  • Clinical: functional scores (Oxford and International Knee Society IKS), pain (from 0 to 6, better to worse outcome), knee mobility in flexion and extension (degrees), frontal and sagittal stability (in degrees and mm), joint sounds, Forgotten Joint Score (FJS).

The scores are mostly qualitative and all of them will be globally evaluated by the investigator regarding to the patient status.

-Radiographic: X-rays of the front and profile of the prosthesis, positioning of the implants (angle, axis), existence of borders (bone cement, prosthesis cement), presence of osteolysis or any notable element.

MRI will be performed to evaluate the creation of a specific fibrous tissue around the joint that is expected with a ceramic on ceramic bearing.

02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • Total Knee Prosthesis
  • Ceramic on ceramic bearing
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's planned enrollment of 5 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Previously active adult under 70 years of age with disabling knee osteoarthritis resistant to medical treatments (anti-inflammatories, infiltrations, analgesics), with a frontal deformity \< 10° for a primary implantation
  • Written informed consent by the patient
  • Patients affiliated to the French social security system

Exclusion criteria

Exclusion Criteria:

  • Knee deformity > 10
  • Obesity (BMI > 30)
  • Inflammatory rheumatism
  • History of infection
  • Poor skin coverage at the knee joint
  • Known allergy to the materials used and/or anesthetic used in the surgery
  • Repeated falls, major neurological disorders, mental or neuromuscular disorders which can be a source of post-operative complications
  • Significant functional deficit of the collateral ligaments
  • Positive serum or urine pregnancy test for woman with child bearing potential. Pregnancy or within 48 hours post-partum or breast feeding women
  • Phobic patient refusing to have an MRI
  • Patient with a contraindication to have an MRI (active medical devices, metal implants, etc.)
  • Patient under legal protection
  • Patient participating in another Clinical Investigation
  • Post fracture osteoarthritis
  • Osteoporosis
  • Anatomical configuration not allowing the implant to be fixed (depending on size constraints)
  • Disabling comorbidity upon any resumption of physical activity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (estimated)

Study arms

  • Experimental
    CocKnee

    Implementation of CocKnee

    Device: Coc Knee

Interventions

  • DeviceCoc Knee

    Implementation of a ceramic on ceramic knee prosthesis

06

What researchers measure

Primary outcomes

  1. Evaluation of clinical endpoint 1(Oxford score) at 12 months

    Clinical 1 : Oxford functional score : 12 (good) to 60 (bad) 12 questions (1 normal to 5 discomfort )

    Time frame: 1 year

  2. Evaluation of clinical endpoint 2 (IKS score) at 12 months

    Clinical 2 : International Knee Society (IKS) score : * objective component (symptoms) 25 points * subjective component: * expectation (pre or post surgery) 15 points * satisfaction 40 points * function 100 points

    Time frame: 1 year

  3. Evaluation of clinical endpoint 3 (Forgotten Joint score) at 12 months

    Clinical 3 : Forgotten Joint Score (FJS) : 12 questions (0 normal to 4 discomfort ) = Total then FJScore = 100 - (Total x 25)

    Time frame: 1 year

  4. Evaluation of clinical endpoint 4 (Joint sounds) at 12 months

    Clinical 4: Joint sounds : 5 questions, no score

    Time frame: 1 year

  5. Evaluation of clinical endpoint 5 (Pain) at 12 months

    Clinical 5: Pain : 0 to 6

    Time frame: 1 year

  6. Evaluation of clinical endpoint 6 (Knee mobility) at 12 months

    Clinical 6: Knee mobility : Flexion (°) Extension (°)

    Time frame: 1 year

  7. Evaluation of clinical endpoint 7 (Knee stability) at 12 months

    Clinical 7: Knee stability : Frontal (° and mm) Sagittal (° and mm)

    Time frame: 1 year

  8. Evaluation of radiographic endpoints at 12 months

    Radiographic : X-rays of the front and profile of the prosthesis : positioning of the implants (angle, axis), existence of borders (bone cement, prosthesis cement), presence of osteolysis or any notable element.

    Time frame: 1 year

Secondary outcomes

  1. Evaluation of clinical endpoint 1 (Oxford score) at 3 and 6 months and physical capabilities of the patient

    Clinical 1 : Oxford functional score : 12 (good) to 60 (bad) 12 questions (1 normal to 5 discomfort )

    Time frame: 3 and 6 months

  2. Evaluation of clinical endpoint 2 (IKS score) at 3 and 6 months and physical capabilities of the patient

    Clinical 2 : International Knee Society (IKS) score : * objective component (symptoms) 25 points * subjective component: * expectation (pre or post surgery) 15 points * satisfaction 40 points * function 100 points

    Time frame: 3 and 6 months

  3. Evaluation of clinical endpoint 3 (FJ Score) at 3 and 6 months and physical capabilities of the patient

    Clinical 3 : Forgotten Joint Score (FJS) : 12 questions (0 normal to 4 discomfort ) = Total then FJScore = 100 - (Total x 25)

    Time frame: 3 and 6 months

  4. Evaluation of clinical endpoint 4 (Joint sounds) at 3 and 6 months and physical capabilities of the patient

    Clinical 4 : Joint sounds : 5 questions, no score

    Time frame: 3 and 6 months

  5. Evaluation of clinical endpoint 5 (Pain) at 3 and 6 months and physical capabilities of the patient

    Clinical 5 : Pain : 0 to 6

    Time frame: 3 and 6 months

  6. Evaluation of clinical endpoint 6 (Knee mobility) at 3 and 6 months and physical capabilities of the patient

    Clinical 6 : Knee mobility : Flexion (°) Extension (°)

    Time frame: 3 and 6 months

  7. Evaluation of clinical endpoint 7 (Knee stability) at 3 and 6 months and physical capabilities of the patient

    Clinical 7 : Knee stability : Frontal (° and mm) Sagittal (° and mm)

    Time frame: 3 and 6 months

  8. Evaluation of radiographic endpoints at 3 and 6 months and physical capabilities of the patient

    Radiographic : X-rays of the front and profile of the prosthesis : positioning of the implants (angle, axis), existence of borders (bone cement, prosthesis cement), presence of osteolysis or any notable element.

    Time frame: 3 and 6 months

  9. Evaluation of fibrous tissue

    Evaluation of fibrous tissue around the prosthesis: Performance of ultrasounds and MRI at 3, 6 and 12 months postoperatively, allowing to evaluate and measure (in mm) the thickness and progression of fibrous tissue around the prosthesis.

    Time frame: 1 year

  10. Validation of the ancillary equipment used and the prosthesis surgical technique

    Notification of any malfunction noticed during the use of ancillary equipment

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • Hôpital Lariboisière
    Paris, 75010, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06592248
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Dec 19, 2024
Primary completion
Dec 19, 2025 (estimated)
Completion
Dec 19, 2026 (estimated)
Last update
Jan 15, 2025

Study contacts

Pascal BIZOT, MD, Pr
Contact
pascal.bizot@aphp.fr
+33 (0)1 49 95 91 34
Pascal BIZOT, MD, Pr
principal investigator · APHP
Laurent SEDEL, MD, Pr
study director · CC/ Contact

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion